Cargando…

SARS vaccine to receive funding in the US

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141170/
http://dx.doi.org/10.1007/BF03276914
_version_ 1783519138296102912
collection PubMed
description
format Online
Article
Text
id pubmed-7141170
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-71411702020-04-09 SARS vaccine to receive funding in the US PharmacoEcon Outcomes News News Item Springer International Publishing 2013-02-10 2003 /pmc/articles/PMC7141170/ http://dx.doi.org/10.1007/BF03276914 Text en © Adis International Ltd 2003 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle News Item
SARS vaccine to receive funding in the US
title SARS vaccine to receive funding in the US
title_full SARS vaccine to receive funding in the US
title_fullStr SARS vaccine to receive funding in the US
title_full_unstemmed SARS vaccine to receive funding in the US
title_short SARS vaccine to receive funding in the US
title_sort sars vaccine to receive funding in the us
topic News Item
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141170/
http://dx.doi.org/10.1007/BF03276914